Frontier Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-289,627
Closed -$18M 288
2023
Q4
$18M Buy
289,627
+18,880
+7% +$1.06M 0.18% 172
2023
Q3
$15.2M Buy
270,747
+56,005
+26% +$3.15M 0.17% 169
2023
Q2
$10.8M Buy
214,742
+157,641
+276% +$8.39M 0.1% 189
2023
Q1
$3.12M Sell
57,101
-119,472
-68% -$6.98M 0.03% 242
2022
Q4
$11M Buy
176,573
+47,408
+37% +$3.15M 0.12% 193
2022
Q3
$9.1M Sell
129,165
-111,415
-46% -$7.68M 0.11% 203
2022
Q2
$13.6M Sell
240,580
-120,621
-33% -$6.61M 0.16% 183
2022
Q1
$22.6M Sell
361,201
-40,146
-10% -$2.16M 0.2% 157
2021
Q4
$22.5M Sell
401,347
-122,036
-23% -$7.46M 0.18% 165
2021
Q3
$34.1M Buy
523,383
+52,530
+11% +$3.59M 0.27% 132
2021
Q2
$29.9M Buy
+470,853
New +$27.8M 0.22% 160

Other funds holding AXNX

Frontier Capital Management's AXNX Position: Q1 2024 in Review

Frontier Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 289,627 shares — an estimated $18M sold.

Frontier Capital Management first reported a position in AXNX in Q2 2021 and held it in 11 quarters. The position peaked at $34.1M in Q3 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Frontier Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Frontier Capital Management sold 289,627 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $18M.
  • Frontier Capital Management first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Frontier Capital Management's Axonics, Inc. Common Stock position peaked at $34.1M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Frontier Capital Management's 13F filing for Q1 2024, filed 15 May 2024.